ABSTRACT
INTRODUCTION
Acquired Immunodeficiency Syndrome (AIDS) is caused by HIV-1 or HIV-2. HIV-1 is widespread, whereas HIV-2 is primarily found in West-Africa. Although both viruses have only limited sequence similarity (42% on the nucleotide level), they cause a disease with similar symptoms. HIV-2 is more related to simian immunodeficiency virus (SIV) than to HIV-1 (1) .
An essential step in the retroviral lifecycle is the integration of a double stranded DNA copy of the viral genomic RNA into the host genome. From studies of retroviral integration in vitro the following picture of the reaction has emerged (reviewed in 2). The 3' terminal two nucleotides are removed from both ends of the double-stranded linear viral DNA (3) (4) (5) (6) . Subsequently, target DNA is cut in a staggered fashion, which leaves 5' protruding ends, and the 3' ends of the viral DNA are ligated to the 5' protrusions of the target DNA (7, 8) . This One retroviral protein is required for the integration reaction: IN. Mutations in the IN coding region of the pol gene result in retroviruses that are defective in integration (9, 10) . Various assays have been developed to test for activities of (partially) purified IN protein. IN proteins of several retroviruses have been shown to be able to cut off two nucleotides from the 3' end of double-stranded oligonucleotides that mimic the viral DNA ends (6, 11, 12) . In the same assay, integration of one oligonucleotide into another was observed (3, 4, (13) (14) (15) (16) . IN has only limited substrate specificity: most point mutations in the viral DNA do not severely affect specific cleavage and integration (14, 17) , and the IN protein of Moloney murine leukemia virus (MoMLV) can mediate integration of DNA substrates with HIV DNA ends (13, 18) . Probably IN function does not require much specificity, since IN remains in the viral core particle when the double-stranded DNA copy is synthesized, and it does not need to search a whole cellular genome for its specific viral sites (19, 20) .
Although it has been established that partially purified HIV IN can carry out the integration reaction, it had not been excluded that contaminating host proteins are essential for the reaction. The IN protein of avian sarcoma leukosis virus, judged to be pure on a coomassie stained gel, is sufficient for integration in vitro (4) , and by analogy one would expect that pure IN would also be sufficient for integration of mammalian retroviruses such as HIV. In this study we addressed this by determining the activity of purified HIV-1 and HIV-2 IN.
We studied the IN proteins of both HIV types for the following (6, (21) (22) (23) (24) (25) . Also specific binding of MoMLV IN to the viral DNA ends in a South-Western assay was reported (26) . The IN proteins of MoMLV and HIV-1 were reported to bind specifically to viral DNA termini in a mobility shift assay (27 -29 
SDS-PAGE analysis
Protein samples were subjected to electrophoresis in 10% SDSpolyacrylamide minigels (Biorad) and visualized by either coomassie brilliant blue staining or silver staining (silver stain kit, purchased from Sigma). To obtain increased sensitivity, the silver staining procedure was done twice (as described by the supplier). The cleavage and integration reactions were carried out essentially as described for MoMLV IN (7). The standard reaction mixture contained 20 mM MOPS pH 7.2, 75 mM NaCl, 10 mM DTT, 20% glycerol (v/v), 100 ,g/ml bovine serum albumin, 3 (30) . Gels were dried and reaction products were visualized by autoradiography. To quantitate the reaction, cleaved and uncleaved products were excised from the gel. Gelslices were incubated overnight in scintillation cocktail (Ultima Gold, Packard) and their radioactivity was determined in a scintillation counter.
Cleavage and integration reactions
Mobility shift assay Binding reactions were performed under the same conditions as the cleavage reactions or under conditions that were essentially the same as described for HIV-1 IN binding (29) polyacrylamide gels in 1/2 xTBE at room temperature (5V/cm). Gels were dried and products were visualized by autoradiography.
As shown in figure 2, HIV-1 and HIV-2 IN have similar substrate preferences: they both act on HIV-1 and HIV-2 substrates with equal efficiency. For both IN proteins U5 is a somewhat better substrate than U3. However, the U5 end of MoMLV, a more distantly related retrovirus with DNA ends that differ significantly from HIV DNA ends (8 out of 15 nucleotides are similar at the U3 end and 6 out of 15 at the U5 end), was cleaved with much lower efficiency than HIV DNA ends, and no integration products were detected ( figure 2 lanes 14 and 15) , not even after long exposure times (not shown). HIV-2 IN cleaved the MoMLV substrate primarily at the expected position, 3' of the conserved CA sequence. Since there is some aspecific nuclease activity in the HIV-l IN preparation, no specific cutting of MoMLV DNA ends could be detected above the background.
In this assay also products were formed, that were longer than the substrate ( figure 2 lanes 6 and 12) (6, 14, 17) . HIV-2 IN was tested for the same activities. As shown in figure  2 (lanes 9 and 12) , purified HIV-2 IN was able to cut off two nucleotides from the 3' end of oligonucleotide substrates that represent the HIV-2 DNA ends. We investigated whether the In the standard cleavage reaction with HIV-2 IN the protein to DNA ratio is 15: 1 on a molar basis. Under these conditions only 30-50% of the substrate was cleaved. Possibly the reaction is very slow. We therefore investigated the kinetics of the cleavage reaction. As shown in figure 3A the reaction rate was constant for approximately 20 minutes and thereafter decreased. Between one and two hours after start of the reaction some additional cleavage occurred, but the amount of cleaved product did not increase significantly at longer reaction times (results not shown). With a four-fold lower substrate concentration a comparable curve was obtained for the time course ( figure 3A) , showing that the decrease in reaction rate is independent of the concentration of substrate or product. The level of cleavage was linear with IN concentration (figure 3B) and not with substrate concentration ( figure 3C ), supporting the conclusion that the amount of IN is rate limiting in this assay. The incomplete conversion of substrate to cut product can be explained by slow inactivation, probably due to aggregation and precipitation of IN (see below). Competition of the cleavage reaction The cutting and integration reaction is sequence specific: only linear DNA with a specific viral sequence at its end can be cut and integrated. This implies that IN specifically recognizes these sequences. We investigated whether this specific recognition could be outcompeted by an excess of DNA of aspecific as well as specific sequence. As shown in figure 4A (lanes 3-6) the cleavage reaction was strongly competed by oligonucleotides that mimic the HIV-1 U5 as well as U3 DNA ends. Surprisingly, MoMLV DNA ends, and even a double-stranded 28-mer oligonucleotide of a sequence unrelated to viral DNA ends, also competed in the cleavage reactions ( figure 4A lanes 7-10) . The aspecific oligonucleotides competed approximately three-fold less strongly than specific competitors (as determined by counting radioactivity in excised gelslices). Since efficient cleavage requires that the specific viral DNA sequence is present near the end of linear DNA (17), we tested whether DNA ends are required for competition in the cutting reaction. As shown in figure 4A ( lanes 11) 8) . All competitor preparations were heated to 80°C and allowed to anneal by slow cooling. 10) , aspecific double-stranded 28-mer oligonucleotides (lanes 11 and 12), pBR322 (lanes 13 and 14) , or yeast tRNA (lanes 15 and 16). After one hour incubation, the reactions were centrifuged for 30 minutes at 10,000 xg.
Lanes labeled 'S' contain supematants and lanes labeled 'P' contain pellets. Without competition more than 50 % of the DNA coprecipitated, whereas in the reactions with a 20-fold excess of specific as well as aspecific competitor hardly any radioactive DNA was found in the pellet (figure SC). The ratio of cleaved product to uncleaved substrate was not similar in pellet and supernatant: the pellet contained a larger proportion of cleaved product than the supernatant ( figure SC lanes 3 and 4) . This effect is stronger in the presence of competitor (figure SC lanes 5- (13, 18) . From the results presented here we conclude that IN can recognize a wide range of substrates with similarity to viral DNA ends. An extensive analysis of HIV-1 IN substrate requirements by mutagenesis of viral DNA sequences resulted in a similar conclusion (17) .
We found no specific DNA binding of IN in mobility shift assays, nor did we see any specificity if we isolated aggregated IN by centrifugation and determined whether viral DNA was bound preferentially. In the latter case we know the interaction between IN and substrate was productive, because a large proportion of the substrate DNA that was bound was cut within an hour; nevertheless this binding of substrate to IN could be competed out by aspecific DNA. Together with the observation that addition of competitor DNA after a short preincubation with the labeled DNA hardly affects the extent of cleavage, this leads to the following picture of IN action in vitro: in reaction buffer (under near physiological salt concentrations) IN quickly binds to nucleic acids with little sequence specificity (and also aggregates). Once bound to DNA, IN can slowly cut a specific viral sequence. It probably remains bound to the cleaved DNA and can mediate integration into target DNA. If IN does not find a specific site it also remains bound. This picture of IN action in vitro probably does not reflect the mechanism of recognition of viral DNA in vivo: in the infected cell IN is in constant proximity of HIV RNA, or, after reverse transcription, of HIV DNA, in the viral core particle. This suggests that IN is probably never free in solution; it may be bound first to viral RNA and later to viral DNA, which can explain why IN does not need to be very soluble under physiological salt concentrations. The presence of IN in core particles can also explain its loose substrate specificity. IN is probably continuously present near the viral DNA, and it only needs to recognize the specific sequence for precise positioning. This requires a specificity of another order of magnitude than e.g. the specific recognition of enhancers in a cellular genome by transcription factors.
In light of these results it is not easy to understand the observations of others who reported specific binding by recombinant MoMLV or HIV IN (27, 29) . The HIV IN preparations that showed specific DNA binding were not pure, and no speAific cutting or integration by these protein preparations was reported. Using pure and active HIV IN we find competition of any binding by aspecific DNA, and this is consistent with our observations that also cutting and integration of specific substrates is competed out by aspecific DNA. Whatever the explanation is for the band shifts observed by others, specific DNA binding does not seem to be an intrinsic property of active HIV IN.
